Search
for
Sort by
Research 781–810 of 1000+
- Hirsutism Beyond PCOS: Genome-wide Evidence for Genetic Factors
- Could the Risk of Chronic Degenerative Valve Disease (CDVD) in Dogs Depend on Exposure to Endocrine-Disrupting Chemicals Polluting the Environment?
- Insulin-like Growth Factor 1 (IGF-1) in Hair Regeneration: Mechanistic Pathways and Therapeutic Potential
- Hair greying & its palliative management
- Polycystic Ovarian Morphology is Associated with Hyperandrogenemia and Insulin Resistance in Women with Polycystic Ovary Syndrome (PCOS)
- Influence of Vitamin D on the Incidence of Metabolic Syndrome and Hormonal Balance in Patients with Polycystic Ovary Syndrome
- Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers
- Recommendations of endocrine treatment for patients with gender dysphoria
- The Effect of Sex on the Risk of Long-COVID and Cardiovascular Complications in Healthy Patients without Comorbidities: Data from a Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study
- Enhancing Skin Anti-Aging through Healthy Lifestyle Factors
- Business Continuity and Risk Mitigation in the Pharmaceutical Industry: Strengthening Supply Chains for Pandemic Preparedness
- Evaluation of ischemia-modified albumin level and parameters related with oxidative stress in early onset androgenetic alopecia
- Should Male Pattern Baldness Be Considered in Prostate Cancer Risk Assessment? A Systematic Review and Meta-analysis
- Clinical Insights and Prognostic Factors in Frontal Fibrosing Alopecia and Lichen Planopilaris: A Retrospective Cohort Study
- A Review and a Brief Explanation of the Poly Cystic Ovarian Syndrome
- The complex relationship between TFEB transcription factor phosphorylation and subcellular localization
- Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors
- Male pattern baldness and prostate cancer risk in a population-based case–control study
- Correlation of skin changes with hormonal changes in polycystic ovarian syndrome: A cross-sectional study clinical study
- May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
- Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome
- Association of Spironolactone Use With Risk of Cancer
- Clinical review 74: Dermatological manifestations of endocrine disorders.
- Role of testosterone in SARS-CoV-2 infection: A key pathogenic factor and a biomarker for severe pneumonia
- Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans
- Obstructive sleep apnea, low transferrin saturation levels, and male‐pattern baldness
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Potential Role of Cinnamon (<i>Cinnamomum verum</i>) to Reduce the Risk of Polycystic Ovary Syndrome by Managing the Obesity: A Review
- Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring
- Polycystic Ovary Syndrome: Conditions, Genetics and Current Cure